Healthcare PR - February 2011

As pharma companies negotiate the prospect of a fundamentally changed NHS and a new drug pricing system, our writers look for the threats and opportunities of the new landscape. Plus - interview with GSK's v-p, global comms, Phil Thomson.


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in